ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes

Published:2017-03-08 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Cho Haaglim,Um JungIn,Lee Ji-Hyung,Kim Woong-Hee,Kang Wan Seok,Kim So Hun,Ha Hyung-Ho,Kim Yong-Chul,Ahn Young-Keun,Jung Da-Woon,Williams Darren R.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep44186.pdf

Reference62 articles.

1. Seuring, T., Archangelidi, O. & Suhrcke, M. The Economic Costs of Type 2 Diabetes: A Global Systematic Review. PharmacoEconomics 33, 811–831, doi: 10.1007/s40273-015-0268-9 (2015).

2. Geaney, F., Scutaru, C., Kelly, C., Glynn, R. W. & Perry, I. J. Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping. PLoS One 10, e0133009, doi: 10.1371/journal.pone.0133009 (2015).

3. Forouhi, N. G. & Wareham, N. J. Epidemiology of diabetes. Medicine 42, 698–702, doi: 10.1016/j.mpmed.2014.09.007 (2014).

4. Silva, F. S., Oliveira, P. J. & Duarte, M. F. Oleanolic, Ursolic, and Betulinic Acids as Food Supplements or Pharmaceutical Agents for Type 2 Diabetes: Promise or Illusion? Journal of agricultural and food chemistry 64, 2991–3008, doi: 10.1021/acs.jafc.5b06021 (2016).

5. Nissen, S. E. & Wolski, K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England journal of medicine 356, 2457–2471, doi: 10.1056/NEJMoa072761 (2007).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination;Cancer Letters;2024-07

2. Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD);Journal of Clinical & Translational Endocrinology;2024-06

3. A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle;Current Obesity Reports;2024-05-04

4. Glycolytic enzyme Enolase-1 regulates insulin gene expression in pancreatic β-cell;Biochemical and Biophysical Research Communications;2024-04

5. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway;Molecular Carcinogenesis;2024-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3